Global Plasmid CDMO Services Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI03259530

Publication Date:

March 31, 2025

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Plasmid CDMO Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Plasmid CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Plasmid CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Plasmid CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Plasmid CDMO Services players cover GenScript ProBio, PackGene Biotech, Hillgene, Porton Advanced Solutions, Catalent, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧lasmid CDMO Services Industry Forecast鈥� looks at past sales and reviews total world Plasmid CDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Plasmid CDMO Services sales for 2025 through 2031. With Plasmid CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmid CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Plasmid CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plasmid CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Plasmid CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmid CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmid CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasmid CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade
Segmentation by Application:
Biopharmaceutical Company
Academic Scientific Research Institution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript ProBio
PackGene Biotech
Hillgene
Porton Advanced Solutions
Catalent
VectorBuilder
Ubrigene
Charles River Laboratories
Obio Technology (Shanghai)
Wacker Biotech US
Biovian
Curia
Lotuslake Biomedical
VGXI
Andelyn Biosciences
Esco Aster
BioCina
Merck

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasmid CDMO Services Market Size (2020-2031)
2.1.2 Plasmid CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Plasmid CDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Plasmid CDMO Services Segment by Type
2.2.1 IIT Grade
2.2.2 IND Grade
2.2.3 Clinical Trial Grade
2.2.4 Commercial Production Grade
2.3 Plasmid CDMO Services Market Size by Type
2.3.1 Plasmid CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Plasmid CDMO Services Market Size Market Share by Type (2020-2025)
2.4 Plasmid CDMO Services Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Academic Scientific Research Institution
2.5 Plasmid CDMO Services Market Size by Application
2.5.1 Plasmid CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Plasmid CDMO Services Market Size Market Share by Application (2020-2025)
3 Plasmid CDMO Services Market Size by Player
3.1 Plasmid CDMO Services Market Size Market Share by Player
3.1.1 Global Plasmid CDMO Services Revenue by Player (2020-2025)
3.1.2 Global Plasmid CDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Plasmid CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Plasmid CDMO Services by Region
4.1 Plasmid CDMO Services Market Size by Region (2020-2025)
4.2 Global Plasmid CDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Plasmid CDMO Services Market Size Growth (2020-2025)
4.4 APAC Plasmid CDMO Services Market Size Growth (2020-2025)
4.5 Europe Plasmid CDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Plasmid CDMO Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Plasmid CDMO Services Market Size by Country (2020-2025)
5.2 Americas Plasmid CDMO Services Market Size by Type (2020-2025)
5.3 Americas Plasmid CDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasmid CDMO Services Market Size by Region (2020-2025)
6.2 APAC Plasmid CDMO Services Market Size by Type (2020-2025)
6.3 APAC Plasmid CDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Plasmid CDMO Services Market Size by Country (2020-2025)
7.2 Europe Plasmid CDMO Services Market Size by Type (2020-2025)
7.3 Europe Plasmid CDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasmid CDMO Services by Region (2020-2025)
8.2 Middle East & Africa Plasmid CDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Plasmid CDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Plasmid CDMO Services Market Forecast
10.1 Global Plasmid CDMO Services Forecast by Region (2026-2031)
10.1.1 Global Plasmid CDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Plasmid CDMO Services Forecast
10.1.3 APAC Plasmid CDMO Services Forecast
10.1.4 Europe Plasmid CDMO Services Forecast
10.1.5 Middle East & Africa Plasmid CDMO Services Forecast
10.2 Americas Plasmid CDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Plasmid CDMO Services Forecast
10.2.2 Canada Market Plasmid CDMO Services Forecast
10.2.3 Mexico Market Plasmid CDMO Services Forecast
10.2.4 Brazil Market Plasmid CDMO Services Forecast
10.3 APAC Plasmid CDMO Services Forecast by Region (2026-2031)
10.3.1 China Plasmid CDMO Services Market Forecast
10.3.2 Japan Market Plasmid CDMO Services Forecast
10.3.3 Korea Market Plasmid CDMO Services Forecast
10.3.4 Southeast Asia Market Plasmid CDMO Services Forecast
10.3.5 India Market Plasmid CDMO Services Forecast
10.3.6 Australia Market Plasmid CDMO Services Forecast
10.4 Europe Plasmid CDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Plasmid CDMO Services Forecast
10.4.2 France Market Plasmid CDMO Services Forecast
10.4.3 UK Market Plasmid CDMO Services Forecast
10.4.4 Italy Market Plasmid CDMO Services Forecast
10.4.5 Russia Market Plasmid CDMO Services Forecast
10.5 Middle East & Africa Plasmid CDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Plasmid CDMO Services Forecast
10.5.2 South Africa Market Plasmid CDMO Services Forecast
10.5.3 Israel Market Plasmid CDMO Services Forecast
10.5.4 Turkey Market Plasmid CDMO Services Forecast
10.6 Global Plasmid CDMO Services Forecast by Type (2026-2031)
10.7 Global Plasmid CDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Plasmid CDMO Services Forecast
11 Key Players Analysis
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Information
11.1.2 GenScript ProBio Plasmid CDMO Services Product Offered
11.1.3 GenScript ProBio Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 GenScript ProBio Main Business Overview
11.1.5 GenScript ProBio Latest Developments
11.2 PackGene Biotech
11.2.1 PackGene Biotech Company Information
11.2.2 PackGene Biotech Plasmid CDMO Services Product Offered
11.2.3 PackGene Biotech Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 PackGene Biotech Main Business Overview
11.2.5 PackGene Biotech Latest Developments
11.3 Hillgene
11.3.1 Hillgene Company Information
11.3.2 Hillgene Plasmid CDMO Services Product Offered
11.3.3 Hillgene Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Hillgene Main Business Overview
11.3.5 Hillgene Latest Developments
11.4 Porton Advanced Solutions
11.4.1 Porton Advanced Solutions Company Information
11.4.2 Porton Advanced Solutions Plasmid CDMO Services Product Offered
11.4.3 Porton Advanced Solutions Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Porton Advanced Solutions Main Business Overview
11.4.5 Porton Advanced Solutions Latest Developments
11.5 Catalent
11.5.1 Catalent Company Information
11.5.2 Catalent Plasmid CDMO Services Product Offered
11.5.3 Catalent Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Catalent Main Business Overview
11.5.5 Catalent Latest Developments
11.6 VectorBuilder
11.6.1 VectorBuilder Company Information
11.6.2 VectorBuilder Plasmid CDMO Services Product Offered
11.6.3 VectorBuilder Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 VectorBuilder Main Business Overview
11.6.5 VectorBuilder Latest Developments
11.7 Ubrigene
11.7.1 Ubrigene Company Information
11.7.2 Ubrigene Plasmid CDMO Services Product Offered
11.7.3 Ubrigene Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Ubrigene Main Business Overview
11.7.5 Ubrigene Latest Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Information
11.8.2 Charles River Laboratories Plasmid CDMO Services Product Offered
11.8.3 Charles River Laboratories Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Charles River Laboratories Main Business Overview
11.8.5 Charles River Laboratories Latest Developments
11.9 Obio Technology (Shanghai)
11.9.1 Obio Technology (Shanghai) Company Information
11.9.2 Obio Technology (Shanghai) Plasmid CDMO Services Product Offered
11.9.3 Obio Technology (Shanghai) Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Obio Technology (Shanghai) Main Business Overview
11.9.5 Obio Technology (Shanghai) Latest Developments
11.10 Wacker Biotech US
11.10.1 Wacker Biotech US Company Information
11.10.2 Wacker Biotech US Plasmid CDMO Services Product Offered
11.10.3 Wacker Biotech US Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Wacker Biotech US Main Business Overview
11.10.5 Wacker Biotech US Latest Developments
11.11 Biovian
11.11.1 Biovian Company Information
11.11.2 Biovian Plasmid CDMO Services Product Offered
11.11.3 Biovian Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Biovian Main Business Overview
11.11.5 Biovian Latest Developments
11.12 Curia
11.12.1 Curia Company Information
11.12.2 Curia Plasmid CDMO Services Product Offered
11.12.3 Curia Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Curia Main Business Overview
11.12.5 Curia Latest Developments
11.13 Lotuslake Biomedical
11.13.1 Lotuslake Biomedical Company Information
11.13.2 Lotuslake Biomedical Plasmid CDMO Services Product Offered
11.13.3 Lotuslake Biomedical Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Lotuslake Biomedical Main Business Overview
11.13.5 Lotuslake Biomedical Latest Developments
11.14 VGXI
11.14.1 VGXI Company Information
11.14.2 VGXI Plasmid CDMO Services Product Offered
11.14.3 VGXI Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 VGXI Main Business Overview
11.14.5 VGXI Latest Developments
11.15 Andelyn Biosciences
11.15.1 Andelyn Biosciences Company Information
11.15.2 Andelyn Biosciences Plasmid CDMO Services Product Offered
11.15.3 Andelyn Biosciences Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Andelyn Biosciences Main Business Overview
11.15.5 Andelyn Biosciences Latest Developments
11.16 Esco Aster
11.16.1 Esco Aster Company Information
11.16.2 Esco Aster Plasmid CDMO Services Product Offered
11.16.3 Esco Aster Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Esco Aster Main Business Overview
11.16.5 Esco Aster Latest Developments
11.17 BioCina
11.17.1 BioCina Company Information
11.17.2 BioCina Plasmid CDMO Services Product Offered
11.17.3 BioCina Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 BioCina Main Business Overview
11.17.5 BioCina Latest Developments
11.18 Merck
11.18.1 Merck Company Information
11.18.2 Merck Plasmid CDMO Services Product Offered
11.18.3 Merck Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Merck Main Business Overview
11.18.5 Merck Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂